Stay updated on Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial

Sign up to get notified when there's something new on the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The government funding notice banner on the page has been removed. The study details and navigation remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:00:11.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Results-related information has been added to the Study Record Dates, including a newly posted results entry dated 2024-04-04 and related QC updates. The page now reflects posted results and completed study record updates.
    Difference
    0.4%
    Check dated 2025-11-03T21:08:08.000Z thumbnail image
  4. Check
    48 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    4%
    Check dated 2025-10-06T05:50:52.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:32.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2; 'Back to Top' link removed. No substantive changes to core content.
    Difference
    0.2%
    Check dated 2025-09-14T19:58:07.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T16:59:15.000Z thumbnail image

Stay in the know with updates to Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page.